**Recent executive actions and administrative proceedings have shaped trader views on federal cannabis rescheduling.** President Trump's December 2025 executive order directed expedited movement of marijuana to Schedule III under the Controlled Substances Act. In April 2026, the Department of Justice immediately reclassified FDA-approved marijuana products and state-licensed medical cannabis to Schedule III while launching an expedited hearing process for broader rescheduling of all marijuana from Schedule I. That hearing began June 29, 2026, and was scheduled to conclude by mid-July, with firm procedural deadlines intended to accelerate a potential final DEA rule. Traders monitor hearing outcomes, any resulting notice-and-comment rulemaking, and related agency actions for signals on full rescheduling timelines, as these directly influence implied probabilities in related prediction markets.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado$795,647 Vol.
30 de septiembre
14%
31 de diciembre
27%
$795,647 Vol.
30 de septiembre
14%
31 de diciembre
27%
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Mercado abierto: Feb 7, 2026, 5:04 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...**Recent executive actions and administrative proceedings have shaped trader views on federal cannabis rescheduling.** President Trump's December 2025 executive order directed expedited movement of marijuana to Schedule III under the Controlled Substances Act. In April 2026, the Department of Justice immediately reclassified FDA-approved marijuana products and state-licensed medical cannabis to Schedule III while launching an expedited hearing process for broader rescheduling of all marijuana from Schedule I. That hearing began June 29, 2026, and was scheduled to conclude by mid-July, with firm procedural deadlines intended to accelerate a potential final DEA rule. Traders monitor hearing outcomes, any resulting notice-and-comment rulemaking, and related agency actions for signals on full rescheduling timelines, as these directly influence implied probabilities in related prediction markets.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado



Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes